LOTRONEX® FDA Gastrointestinal Drugs Advisory Committee

3/16/01


Click here to start


Table of Contents

LOTRONEX® FDA Gastrointestinal Drugs Advisory Committee

LOTRONEX

FDA Request for Advisory Meeting

Risk Management for Lotronex

Fundamental Questions

Has the Safety Profile Changed?

Risk Management Program

Summary

Glaxo Wellcome Presentation: AGENDA

Author: stj11454